Cardiothoracic Surgeons in Pandemics: Ethical Considerations

Drake, Daniel H.; Morrow, Cynthia D; Kinlaw, Kathleen; Bonis, Michele De; Zangrillo, Alberto; Sade, Robert M.; Blitzer, David; Carpenter, Andrea J.; Ceppa, Duy Khanh P.; Chen, Edward P.; Cohen, Robbin G.; D’Amico, Thomas A.; Entwistle, John W.; Fedak, Paul W.M.; Fenton, Kathleen N.; Loebe, Matthias; Mayer, John E.; McKneally, Martin F.; Merrill, Walter H.; Millikan, Scott J.; Moffatt-Bruce, Susan D.; Murthy, Sudish C.; Naunheim, Keith S.; Pickens, Allan; Ray, Shuddhadeb; Romano, Jennifer C.; Starnes, Sandra L.; Swain, Julie A.; Tweddell, James S.; Whyte, Richard I.; Wood, Douglas D.; Zwischenberger, Joseph B.

doi:10.1016/j.athoracsur.2020.03.006

Cited by 10 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Independientemente de su riesgo, es indispensable conocer la anatomía coronaria en todos los pacientes y de acuerdo con los hallazgos evaluar el método de revascularización. Esta conducta habitual, al igual que ocurre con el IAMCEST, se ha modificado durante la pandemia y se replican varias de las posturas descritas para los SICA con elevación del segmento ST 26 .…”

Section: Síndromes Coronariosunclassified

Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

Alcocer-Gamba¹,

Gutiérrez-Fajardo²,

Cabrera-Rayo³

et al. 2021

ACM

View full text Add to dashboard Cite

The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a comprehensive and consensual review and analysis of the topics related to cardiovascular diseases in the COVID-19 pandemic. Scientific positions are analyzed and responsible recommendations on general measures are given to patients, with personal care, healthy eating, regular physical activity, actions in case of cardio-respiratory arrest, protection of the patient and health personnel as well as precise indications in the use of non-invasive cardiovascular imaging, prescription of medications, care in specific topics such as systemic arterial hypertension, heart failure, arrhythmias and acute coronary syndromes, in addition to emphasizing electrophysiology, interventionism, cardiac surgery and in cardiac rehabilitation. The main interest is to provide the medical community with a general orientation on what to do in daily practice and patients with cardiovascular diseases in the setting of this unprecedented epidemiological crisis of

show abstract

Section: Síndromes Coronariosunclassified

Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

Alcocer-Gamba¹,

Gutiérrez-Fajardo²,

Cabrera-Rayo³

et al. 2021

ACM

View full text Add to dashboard Cite

show abstract

“…25 Independientemente de su riesgo, es indispensable conocer la anatomía coronaria en todos los pacientes y, de acuerdo con los hallazgos, evaluar el método de revascularización. Esta conducta habitual, al igual que ocurre con el IAMCEST, se ha modificado durante la pandemia y se replican varias de las posturas descritas para los SICA con elevación del segmento ST. 26…”

Section: Síndromes Coronariosunclassified

Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

Gutiérrez-Fajardo¹,

Alcocer-Gamba²,

Cabrera-Rayo³

et al. 2020

Cardiovasc Metab Sci

View full text Add to dashboard Cite

show abstract

“…Despite the importance of control measures to prevent severe acute respiratory distress syndrome due to coronavirus 2 infection (SARS-CoV-2), pandemic; it has been widely demonstrated that hypertension, diabetes, and cardiovascular disease have a higher risk of adverse outcomes in patients with coronavirus disease-2019 (COVID-19). [1][2][3] As health systems worldwide are focused in the COVID-19 pandemic, we must consider that patients with durable left ventricular assist devices (LVAD) support represent another group population at risk for the disease. 4 We present a case of a patient with destination LVAD therapy, who developed SARS-CoV-2 infection.…”

Section: Introductionmentioning

confidence: 99%

SARS-CoV-2 infection in a patient with destination left ventricular assist device

Careaga-Reyna¹,

Zetina-Tun²

2021

JLPRR

View full text Add to dashboard Cite

Recipients of LVAD for destination therapy may represent a challenge in the treatment of COVID-19. We present a case of a 58 year-old male with LVAD support complicated with SARS-CoV-2 who declines for hospital admission despite interstitial pneumonia and lower O2 saturation. The patient recieved ambulatory support and treatment with anticoagulation, supplementary O2, steroids, antibiotics, ivermectin with succesful evolution and recovery.

show abstract

Cardiothoracic Surgeons in Pandemics: Ethical Considerations

Cited by 10 publications

References 6 publications

Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

SARS-CoV-2 infection in a patient with destination left ventricular assist device

Contact Info

Product

Resources

About